Sfoglia per Autore
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor???Mutated Non???Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
2022 Majem, Margarita; Goldman, Jonathan W.; John, Thomas; Grohe, Christian; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vinh Vu, Huu; Lu, Shun; Li, Shanqing; Young Lee, Kye; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A.; Atagi, Shinji; Zeng, Lingmin; Kulkarni, Dakshayini; Medic, Nenad; Tsuboi, Masahiro; Herbst, Roy S.; Wu, Yi-Long
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP)
2022 Passaro, Antonio; Russo, Giuseppe Lo; Passiglia, Francesco; D'Arcangelo, Manolo; Sbrana, Andrea; Russano, Marco; Bonanno, Laura; Giusti, Raffaele; Metro, Giulio; Bertolini, Federica; Grisanti, Salvatore; Carta, Annamaria; Cecere, Fabiana; Montrone, Michele; Massa, Giacomo; Perrone, Fabiana; Simionato, Francesca; Guaitoli, Giorgia; Scotti, Vieri; Genova, Carlo; Lugini, Antonio; Bonomi, Lucia; Attili, Ilaria; de Marinis, Filippo
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial
2022 Piccirillo, Maria Carmela; Bonanno, Laura; Garassino, Marina Chiara; Esposito, Giovanna; Dazzi, Claudio; Cavanna, Luigi; Burgio, Marco Angelo; Rosetti, Francesco; Rizzato, Simona; Morgillo, Floriana; Cinieri, Saverio; Veccia, Antonello; Papi, Maximilan; Tonini, Giuseppe; Gebbia, Vittorio; Ricciardi, Serena; Pozzessere, Daniele; Ferro, Alessandra; Proto, Claudia; Costanzo, Raffaele; D'Arcangelo, Manolo; Proietto, Manuela; Gargiulo, Piera; Di Liello, Raimondo; Arenare, Laura; De Marinis, Filippo; Crinò, Lucio; Ciardiello, Fortunato; Normanno, Nicola; Gallo, Ciro; Perrone, Francesco; Gridelli, Cesare; Morabito, Alessandro
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practice
2021 Bonanno, L.; Attili, I.; Pavan, A.; Sepulcri, M.; Pasello, G.; Rea, F.; Guarneri, V.; Conte, P.
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center
2021 Pasello, G.; Menis, J.; Pilotto, S.; Frega, S.; Belluomini, L.; Pezzuto, F.; Calio, A.; Sepulcri, M.; Cernusco, N. L. V.; Schiavon, M.; Infante, M. V.; Damin, M.; Micheletto, C.; Del Bianco, P.; Giovannetti, R.; Bonanno, L.; Fantoni, U.; Guarneri, V.; Calabrese, F.; Rea, F.; Milella, M.; Conte, P.
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors
2021 Nardo, Giorgia; Carlet, Jessica; Marra, Ludovica; Bonanno, Laura; Boscolo, Alice; Dal Maso, Alessandro; Boscolo Bragadin, Andrea; Indraccolo, Stefano; Zulato, Elisabetta
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study
2021 Lorenzi, Martina; Ferro, Alessandra; Cecere, Fabiana; Scattolin, Daniela; Del Conte, Alessandro; Follador, Alessandro; Pilotto, Sara; Polo, Valentina; Santarpia, Mariacarmela; Chiari, Rita; Pavan, Alberto; Dal Maso, Alessandro; Da Ros, Valentina; Targato, Giada; Vari, Sabrina; Indraccolo, Stefano; Calabrese, Fiorella; Frega, Stefano; Bonanno, Laura; Conte, Pierfranco; Guarneri, Valentina; Pasello, Giulia
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report
2021 Ferro, A.; Filoni, A.; Pavan, A.; Pasello, G.; Guarneri, V.; Conte, P.; Alaibac, M.; Bonanno, L.
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification
2021 Urso, L.; Silic-Benussi, M.; Boscolo, A.; Lorenzi, M.; Bonanno, L.; Lunardi, F.; Guarneri, V.; Calabrese, F.; Rea, F.; Conte, P.; Pasello, G.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
2021 Dal Maso, A; Lorenzi, M; Ferro, A; Pilotto, S; Cecere, F; Follador, A; Polo, V; Del Conte, A; Sartori, G; Giavarra, M; Scattolin, D; Indraccolo, S; Frega, S; De Maglio, G; Menis, J; Bonanno, L; Calabrese, F; Guarneri, V; Conte, P; Pasello, G
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)
2021 Lorenzi, M.; Dal Maso, A.; Ferro, A.; Polo, V.; Scattolin, D.; Macerelli, M.; Follador, A.; Targato, G.; Indraccolo, S.; Frega, S.; Menis, J.; Bonanno, L.; Guarneri, V.; Conte, P. F.; Pasello, G.
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)
2021 Dal Maso, A.; Pavan, A.; Ferro, A.; Pretelli, G.; Frega, S.; Menis, J.; Pasello, G.; Guarneri, V.; Conte, P. F.; Bonanno, L.
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features
2021 Bonanno, L.; Dal Maso, A.; Pavan, A.; Zulato, E.; Esposito, G.; Fassan, M.; Nardo, G.; Pasello, G.; Guarneri, V.; Calabrese, F.; Rea, F.; Indraccolo, S.; Conte, P. F.
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
2021 Pavan, Alberto; Boscolo Bragadin, Andrea; Calvetti, Lorenzo; Ferro, Alessandra; Zulato, Elisabetta; Attili, Ilaria; Nardo, Giorgia; Dal Maso, Alessandro; Frega, Stefano; Menin, Andrea Giovanni; Fassan, Matteo; Calabrese, Fiorella; Pasello, Giulia; Guarneri, Valentina; Aprile, Giuseppe; Conte, Pierfranco; Rosell, Rafael; Indraccolo, Stefano; Bonanno, Laura
Implementation of next generation sequencing-based liquid biopsy for clinical molecular diagnostics in non-small cell lung cancer (Nsclc) patients
2021 Zulato, E.; Tosello, V.; Nardo, G.; Bonanno, L.; Del Bianco, P.; Indraccolo, S.
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards
2021 Danesi, R; Fogli, S; Indraccolo, S; Del Re, M; Dei Tos, A P; Leoncini, L; Antonuzzo, L; Bonanno, L; Guarneri, V; Pierini, A; Amunni, G; Conte, P
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer
2021 Gregorc, Vanesa; Mazzarella, Luca; Lazzari, Chiara; Graziano, Paolo; Vigneri, Paolo; Genova, Carlo; Toschi, Luca; Ciliberto, Gennaro; Bonanno, Laura; Delmonte, Angelo; Bucci, Gabriele; Rossi, Antonio; Motta, Gianmarco; Coco, Simona; Marinello, Arianna; Buglioni, Simonetta; Cangi, Maria Giulia; Di Micco, Concetta; Bandiera, Alessandro; Bonfiglio, Silvia; Pecciarini, Lorenza; Guida, Alessandro; Ceol, Arnaud; Frige’, Gianmaria; De Maria, Ruggero; Pelicci, Pier Giuseppe
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
2021 Wu, Yi-Long; John, Thomas; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W.; Kim, Sang-We; Kato, Terufumi; Laktionov, Konstantin; Vu, Huu Vinh; Wang, Zhijie; Lu, Shun; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A.; Zeng, Lingmin; Atasoy, Ajlan; Herbst, Roy S.; Tsuboi, Masahiro
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
2021 Wu, Yi-Long; Tsuboi, Masahiro; John, Thomas; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S
Lung cancer (LC) in HIV positive patients: Pathogenic features and implications for treatment
2020 Frega, S.; Ferro, A.; Bonanno, L.; Guarneri, V.; Conte, P.; Pasello, G.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile